OncoSec Announces Closing of 1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
| ONCSDelisted Stock | USD 0.06 0 3.63% |
Slightly above 61% of OncoSec Medical's investor base is looking to short. The analysis of current outlook of investing in OncoSec Medical suggests that many traders are alarmed regarding OncoSec Medical's prospects. OncoSec Medical's investing sentiment can be driven by a variety of factors including economic data, OncoSec Medical's earnings reports, geopolitical events, and overall market trends.
OncoSec |
OncoSec Medical Incorporated , a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patients immune system to target cancer cells and eradicate disease, today announced the closing of its previously announced registered direct offering of 1,408,384 shares of its common stock, at a purchase price of 0.945 per share, priced at-the-market under Nasdaq rules. The Company also issued in a concurrent private placem
Read at finance.yahoo.com
 |
OncoSec Medical Fundamental Analysis
We analyze OncoSec Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoSec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoSec Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
OncoSec Medical is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
OncoSec Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OncoSec Medical stock to make a market-neutral strategy. Peer analysis of OncoSec Medical could also be used in its relative valuation, which is a method of valuing OncoSec Medical by comparing valuation metrics with similar companies.
Peers
OncoSec Medical Related Equities
| ZVSA | ZyVersa Therapeutics | 13.76 | ||||
| VRAX | Virax Biolabs | 9.95 | ||||
| IMMX | Immix Biopharma | 6.82 | ||||
| QNRX | Quoin Pharmaceuticals | 4.48 | ||||
| PHIO | Phio Pharmaceuticals | 3.68 | ||||
| DRMA | Dermata Therapeutics | 2.88 | ||||
| PALI | Palisade Bio | 2.15 | ||||
| BDRX | Biodexa Pharmaceticals | 0.99 | ||||
| REVB | Revelation Biosciences | 1.52 | ||||
| UNCY | Unicycive Therapeutics | 2.47 | ||||
| ALLR | Allarity Therapeutics | 4.50 | ||||
| ATNF | 180 Life | 5.49 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |